Advertisement
U.S. Markets open in 8 hrs 1 min
S&P Futures
5,889.25 -3.25 (-0.06%) Dow Futures
43,050.00 -119.00 (-0.28%) Nasdaq Futures
20,526.50 -15.50 (-0.08%) Russell 2000 Futures
2,244.60 -1.60 (-0.07%) Crude Oil
72.24 +0.15 (+0.21%) Gold
2,764.10 +4.30 (+0.16%)
Century Therapeutics, Inc. (IPSC)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Follow
At close: 04:00PM EDT
After hours:
| Previous Close | 1.5400 |
| Open | 1.5200 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 1.4600 - 1.5900 |
| 52 Week Range | 1.2800 - 5.5100 |
| Volume | |
| Avg. Volume | 325,415 |
| Market Cap | 133.851M |
| Beta (5Y Monthly) | 1.37 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.0200 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 10.20 |
ZackselectroCore (ECOR) Stock Jumps 11.7%: Will It Continue to Soar?
electroCore (ECOR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
GlobeNewswireCentury Therapeutics Strengthens Leadership Team with Appointments of Chief Financial Officer and Chief Scientific Officer
- Morgan Conn, Ph.D., seasoned biotech executive with expertise in financing, business development, and corporate strategy, appointed as Chief Financial Officer - - Chad Cowan, Ph.D., cell therapy pioneer, founder, and former CEO of Clade Therapeutics, appointed as Chief Scientific Officer - - Hy Levitsky, M.D., President of Research and Development, to transition to an advisor to Century - PHILADELPHIA, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (NASDAQ: IPSC), an innovative
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.